Showing 2471-2480 of 2494 results for "".
- Thomas Burns, CEO of Glaukos, Joins Avedro’s Board of Directorshttps://modernod.com/news/thomas-burns-ceo-of-glaukos-joins-avedros-board-of-directors/2479974/Avedro announced that Thomas W. Burns has been elected to its board of directors. Mr. Burns has a proven track record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns is President, Chief Executive Officer and a mem
- Unsafe Ocular Stem Cell Treatments Prevalenthttps://modernod.com/news/unsafe-ocular-stem-cell-treatments-prevalent/2479976/Experimental stem cell therapies for eye conditions are being offered at dozens of unregulated clinics in the United States, and some of these procedures are harmful, researchers report. Clinicians should warn their patients against
- Alcon Introduces Ngenuity 3D Visualization System with Datafusion Vitreoretinal Surgery Devicehttps://modernod.com/news/alcon-introduces-ngenuity-3d-visualization-system-with-datafusion-vitreoretinal-surgery-device/2480001/Alcon launched the new Ngenuity 3D Visualization System with Datafusion at the 2018 American Society of Retina Specialists (ASRS) annual meeting. With the addition of the Datafusion software, Ngenuity now also offers integration with the Constellation Vision System for vitreoretinal surgery. The
- OD-OS Achieves Revocation of Iridex MicroPulse Patenthttps://modernod.com/news/od-os-achieves-revocation-of-iridex-micropulse-patent/2480020/OD-OS has achieved the revocation of the MicroPulse Patent (Patent no EP1856774) by Iridex Corporation in oral proceedings at the European Patent office held last Friday in Munich, Germany according to an OD-OS news release. With its successful opposition, OD-OS has cleared the path to man
- Novartis Announces Intention to Spinoff Alcon Into Standalone Companyhttps://modernod.com/news/novartis-announces-intention-to-spinoff-alcon-and-launch-a-5-billion-share-buyback/2480055/After months of speculation, Novartis confirmed on Friday its intention to spinoff Alcon into a separately-traded standalone company. The major transaction would enable Novartis to focus on bringing new drugs to market, while allowing Alcon to focus on its core offerings in the surgical and visio
- Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Hydra-Peg Custom Contact Lens Coatinghttps://modernod.com/news/bausch-lomb-announces-licensing-agreement-with-tangible-science-for-use-of-hydra-peg-custom-contact-lens-coating/2480063/Bausch + Lomb announced that it has entered into a worldwide licensing agreement with Tangible Science, allowing Bausch + Lomb to offer the Tangible Hydra-PEG advanced contact lens coating technology for use with several of its Boston gas permeable (GP) materials and scleral lenses. Terms
- Zeiss Unveils Visulas Green Photocoagulation Laser at WOChttps://modernod.com/news/zeiss-unveils-next-generation-of-ophthalmic-laser-visulas-green-at-world-ophthalmology-congress/2480074/Zeiss unveiled its next-generation Visulas green photocoagulation laser at the World Ophthalmology Congress in Barcelona. Visulas green offers uninterrupted workflow by giving doctors the ability to monitor treatment settings directly from the eyepiece and the abi
- Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Deliveryhttps://modernod.com/news/eyenovia-receives-notices-of-allowance-from-uspto-on-two-additional-patent-applications-for-ophthalmic-drug-delivery/2480109/Eyenovia announced it has received Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for two additional patent applications. The allowed patents provide fundamental coverage on physiologic microdroplet ejection diameters and velocities, which enable gentle delivery of ophthal
- Allergan Shareholders Urge Company to Overhaul Management Structure; Split Role of Chairman and CEOhttps://modernod.com/news/allergan-shareholders-urge-company-to-overhaul-management-structure-split-role-of-chairman-and-ceo/2480116/In a letter sent to Allergan’s board of directors on Tuesday, two company shareholders, Appaloosa Management and Senator Investment Group, called on the drugmaker to divide the roles of chief executive officer and chairman, currently held by Brent Saunders. The investors also urged Allergan
- Automeyes Optical Solutions Receives Patent for its Signature Measurement Technology Benefiting ECPhttps://modernod.com/news/automeyes-optical-solutions-receives-patent-for-its-signature-measurement-technology-benefiting-ecp/2480123/Automeyes Optical Solutions has officially received the patent for the technology behind Automeyes, which was approved by the U.S. Patent Office in February of 2018. Automeyes Founder and creator, Kurt Gardner, was able to prove the methodology was unique and sound enough to receive patent protec